All Pharma News
price-trendAsk Us
Vico Announces First Patient Dosed in Phase 1/2a Clinical Trial of VO659

Vico Announces First Patient Dosed in Phase 1/2a Clinical Trial of VO659
PR NEWSWIRE
03 Apr 2023
Share Share
US FDA grants VICO Therapeutics Orphan-Drug Designation for VO659

US FDA grants VICO Therapeutics Orphan-Drug Designation for VO659
PRNEWSWIRE
29 Jul 2021
Share Share
Vico Therapeutics’ antisense oligonucleotide therapy, VO659

Vico Therapeutics’ antisense oligonucleotide therapy, VO659
PHARMABIZ
11 Feb 2021
Share Share
EC Grants Orphan Drug Designation to Vico Therapeutics’ Oligonucleotide SCA

EC Grants Orphan Drug Designation to Vico Therapeutics’ Oligonucleotide SCA
PHARMTECH
11 Feb 2021
Share Share
European Commission grants Vico Therapeutics Orphan Drug Designation for VO659

European Commission grants Vico Therapeutics Orphan Drug Designation for VO659
PRNEWSWIRE
10 Feb 2021
Share Share
Dutch Vico strengthens leadership team with the appointment of Rupert

Dutch Vico strengthens leadership team with the appointment of Rupert
PRNEWSWIRE
01 Oct 2020
Share Share
European neuro biotech Vico nabs Bayer alum as CMO

European neuro biotech Vico nabs Bayer alum as CMO
Ben Adams FIERCE BIOTEC
01 Oct 2020
Share Share